Grady Lenski.
COLUMBUS, Ohio—Columbus-based ophthalmic medtech startup OcuDoc has named veteran optical industry executive Grady Lenski as chief executive officer. In his new role, Lenski will draw on his extensive experience and deep relationships across the industry to help the firm launch and market a mobile autorefractor known as OcuDoc Mobile that is developing. “Grady is a globally-minded optical industry executive with experience in the C-suite, as a board member, and as consultant for several world-class organizations—he’s the perfect leader for the team as it finalizes development and commercial planning,” emphasized OcuDoc board member and optical industry trailblazer, E. Dean Butler.

Prior to founding his own consultancy, Lenski served as chief marketing officer (CMO) of the Americas for Hoya Vision Care. Before that, he worked at private-equity owned Performance Optics/Vision Ease as CMO and vice president of North American Sales. He enjoyed a long tenure with PPG,  ultimately serving as managing director of adjacencies for Transitions Optical. During his tenure with Transitions he started and led businesses in North America and Asia-Pacific along with leading global business and strategy development.
“I’m thrilled to join the OcuDoc team at this exciting stage of its development. This technology will be a game changer and serve so many worldwide—eyecare professionals (ECPs), retailers, and most importantly their patients and customers,” stated Lenski.
OcuDoc said it is targeting delivery of its prototype device for specific market testing in the second quarter of 2022. It described OcuDoc Mobile as a "smartphone app that can provide accurate, fast, objective autorefraction and Telerefraction, all without the need for additional equipment.”
In the U. S. and other regulated markets, ECPs and retailers will be able to use OcuDoc Mobile as their everyday autorefractor and send the app for patient and caregiver utilization at home, with results delivered back to the ECP, according to OcDoc. In less-regulated markets worldwide, OcuDoc Mobile will provide an objective, accessible, and low-cost solution for vision screening and diagnosis to the billions who lack access to effective care, the company said.
OcuDoc is an ocular medical diagnostic software company whose primary software applications test and monitor vision, enabling both in-person and telemedicine. The company’s software is based on proprietary, patented technology developed at The Ohio State University.